Immunome (IMNM) Stock Chart & Stock Price History $9.79 +0.30 (+3.16%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunome Stock Price Performance The Immunome (IMNM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 38.81%, with a year-to-date return of -7.82%. In the past month, the stock has increased 23.30%, reflecting recent market activity. As of the latest close, Immunome traded at $9.49 with a market cap of $825.74 million and volume of 681,589 shares. Receive IMNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.23%1 Month Performance+23.30%3 Month Performance+6.30%Year-To-Date Performance-7.82%1 Year Performance-38.81% IMNM Stock Chart for Thursday, June, 12, 2025 IMNM Chart by TradingView Immunome Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$9.49$9.79+3.16%$9.91$9.40814,483 shs$851.85 million06/11/2025$9.57$9.49-0.84%$9.77$9.31681,589 shs$825.74 million06/10/2025$9.27$9.57+3.24%$9.68$9.30619,394 shs$832.71 million06/09/2025$9.13$9.27+1.53%$9.43$8.85523,661 shs$806.60 million06/06/2025$9.12$9.13+0.11%$9.55$8.921.23 million shs$794.42 million06/05/2025$9.02$9.12+1.11%$9.34$8.76563,931 shs$793.55 million06/04/2025$9.26$9.02-2.59%$9.56$8.99937,342 shs$784.85 million06/03/2025$9.06$9.26+2.21%$9.47$8.98842,970 shs$805.73 million06/02/2025$8.86$9.06+2.26%$9.24$8.63688,601 shs$788.33 million05/30/2025$8.95$8.86-1.01%$8.90$8.501.21 million shs$770.93 million Get the Latest News and Ratings for IMNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$8.63$8.95+3.71%$9.00$8.58475,381 shs$778.76 million05/28/2025$8.60$8.63+0.35%$9.04$8.63689,788 shs$750.91 million05/27/2025$8.49$8.60+1.30%$8.93$8.321.71 million shs$748.30 million05/26/2025$8.49$8.49$8.52$8.25527,133 shs$738.73 million05/23/2025$8.46$8.49+0.35%$8.52$8.25527,133 shs$738.73 million05/22/2025$7.92$8.46+6.82%$8.53$7.85803,042 shs$736.12 million05/21/2025$8.56$7.92-7.48%$8.45$7.83917,903 shs$689.14 million05/20/2025$8.01$8.56+6.87%$8.61$7.85771,023 shs$744.82 million05/19/2025$8.06$8.01-0.62%$8.44$7.74662,242 shs$696.97 million05/16/2025$8.00$8.06+0.75%$8.18$7.811.13 million shs$701.32 million05/15/2025$7.97$8.00+0.38%$8.09$7.621.21 million shs$696.10 million05/14/2025$7.91$7.97+0.76%$8.07$7.42915,117 shs$693.49 million05/13/2025$7.94$7.91-0.38%$8.37$7.841.77 million shs$688.27 million05/12/2025$7.46$7.94+6.43%$8.10$7.55901,252 shs$690.88 million Related Companies PTGX Stock Chart CPRX Stock Chart CRNX Stock Chart MTSR Stock Chart VKTX Stock Chart MOR Stock Chart SRRK Stock Chart KYMR Stock Chart MLTX Stock Chart IMVT Stock Chart Receive IMNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMNM) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMNM Stock Free IMNM Stock Alerts